Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects.
Osinski V, Bauknight DK, Dasa SSK, Harms MJ, Kroon T, Marshall MA, Garmey JC, Nguyen AT, Hartman J, Upadhye A, Srikakulapu P, Zhou A, O'Mahony G, Klibanov AL, Kelly KA, Boucher J, McNamara CA. Osinski V, et al. Among authors: hartman j. Theranostics. 2020 Jan 1;10(2):585-601. doi: 10.7150/thno.36572. eCollection 2020. Theranostics. 2020. PMID: 31903139 Free PMC article.
Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancer.
Kouvaraki M, Zerdes I, Sifakis EG, Sarafidis M, Matikas A, Tzoras E, Kjällquist U, Stathopoulou K, Lövrot J, Alkodsi A, Hartman J, Sotiriou C, Richard F, Hatschek T, Herold N, Bergh J, Rassidakis GZ, Foukakis T. Kouvaraki M, et al. Among authors: hartman j. Int J Cancer. 2024 Dec 27. doi: 10.1002/ijc.35319. Online ahead of print. Int J Cancer. 2024. PMID: 39729390
Correction to "Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility".
Romero A, Ashcraft L, Chandra A, DiMassa V, Cremin P, Collibee SE, Chuang C, Hartman J, Hwee DT, St Jean D, Malinowski J, DeBenedetto M, Moebius DC, Payette J, Vargas R, Yeoman J, Motani A, Reagan J, Malik FI, Morgan BP. Romero A, et al. Among authors: hartman j. J Med Chem. 2025 Jan 9;68(1):850. doi: 10.1021/acs.jmedchem.4c02850. Epub 2024 Dec 26. J Med Chem. 2025. PMID: 39722587 Free PMC article. No abstract available.
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort.
Sigurjonsdottir G, De Marchi T, Ehinger A, Hartman J, Ullén S, Leandersson K, Bosch A, Staaf J, Killander F, Niméus E. Sigurjonsdottir G, et al. Among authors: hartman j. Breast Cancer Res Treat. 2024 Dec 10. doi: 10.1007/s10549-024-07561-x. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39656429
Metabolic Changes After Bronchoscopic Lung Volume Reduction With Endobronchial Valves in COPD Patients.
van der Molen MC, Posthuma R, Vaes AW, Spruit MA, Gosker HR, Viddeleer AR, Willems TP, Vanfleteren LEGW, Slebos DJ, Hartman JE; SoLVE consortium group. van der Molen MC, et al. Among authors: hartman je. Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00441-1. doi: 10.1016/j.arbres.2024.11.003. Online ahead of print. Arch Bronconeumol. 2024. PMID: 39643514 Free article. English, Spanish.
1,156 results